In the SOUL trial, Rybelsus produced a 14% risk reduction of major adverse cardiovascular events in patients with type 2 ...

That's where Professor Lawrence Appel 's DASH Diet comes in.

Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell ...

There is a donated kidney shortage in the U.S. It’s leaving more than 100,000 people on a years-long waitlist. And despite ...

Nellie Zygiel of Fairhaven has battled illness much of her life. Diagnosed with a rare disease, her life has been saved ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...